Evaluation of ” Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification

• Matthew Phillips

Right here we describe the primary molecular check developed within the early stage of the pandemic to diagnose the primary instances of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection in Sardinian sufferers in February-March 2020, when diagnostic licensed methodology had not but been adopted by scientific microbiology laboratories. The “Caterina assay” is a…